International Business Machines (IBM) — Company Research
Last Updated: 17 June 2026
International Business Machines Corporation (NYSE: IBM) has spent the last five years reinventing itself from a sprawling legacy-hardware conglomerate into a higher-margin software-and-services business built around hybrid cloud and artificial intelligence. Under chairman, president and chief executive officer Arvind Krishna, IBM exited 2025 with its fastest annual revenue growth in years, a generative-AI book of business exceeding $12.5 billion, and 31 consecutive years of dividend increases. This report walks through IBM's structure, financials, valuation and risks using only figures drawn from the company's own SEC filings and press releases.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | International Business Machines Corporation |
| Ticker / Exchange | IBM (NYSE) |
| Sector | Information Technology — software, consulting and infrastructure |
| CEO / Leadership | Arvind Krishna (Chairman, President & Chief Executive Officer); James Kavanaugh (Senior VP & CFO) |
| Headquarters | Armonk, New York, USA |
| Employees | ~286,800 (at 31 Dec 2025, including subsidiaries and temporary/part-time staff; ~264,300 core IBM) |
| FY2025 Revenue | $67.5bn (+8% reported, +6% at constant currency) |
| FY2025 Net income (continuing ops) | $10.6bn (GAAP); operating earnings $11.0bn |
| FY2025 GAAP diluted EPS | $11.14 (operating EPS $11.59) |
| Market cap | ~$252.5bn (mid-June 2026) |
| Quarterly dividend | $1.69 per share (declared April 2026; 31st consecutive annual increase) |
| Most recent results | Q1 2026 (to 31 Mar 2026): revenue $15.9bn, +9%; GAAP EPS $1.28; operating EPS $1.91 |
2. Bull and Bear Case
Bull Case
- Accelerating, software-led growth: FY2025 revenue rose 8% to $67.5bn — the fastest in years — with Software up 11% and the generative-AI book of business now exceeding $12.5bn, evidence the AI strategy is converting to revenue.
- High-quality recurring portfolio: Red Hat hybrid cloud, automation and transaction-processing software carry gross margins above 80%, underpinning durable, sticky revenue and rising operating-margin leverage.
- Strong and growing cash returns: IBM generated $13.2bn of operating cash flow and $14.7bn of free cash flow (its own definition) in FY2025, and raised its dividend for a 31st straight year to $1.69 a quarter.
- Mainframe and infrastructure super-cycle: Infrastructure grew 12% in FY2025 and 15% in Q1 2026 on robust adoption of the next-generation IBM Z platform, with IBM Z revenue up 51% year on year in the quarter.
- Disciplined capital allocation: The $11bn Confluent acquisition (completed March 2026) deepens IBM's data and AI stack while management continues to expand operating pre-tax margins through productivity initiatives.
Bear Case
- Consulting remains sluggish: Consulting revenue was flat at constant currency in FY2025 and grew only 1% at constant currency in Q1 2026, leaving roughly a third of the group exposed to soft enterprise discretionary spending.
- Heavy debt load: Total debt reached $66.4bn at the end of Q1 2026 (up $5.1bn year to date), partly to fund Confluent, against $11.8bn of cash and marketable securities.
- Integration and goodwill risk: Goodwill rose to $74.7bn after recent deals; failure to realise cross-selling from Confluent and other acquisitions could pressure returns and risk future impairment.
- Intense competition in AI and cloud: IBM competes against far larger hyperscalers (Microsoft, AWS, Google) and faster-growing software peers, limiting pricing power in its growth markets.
- Currency and macro sensitivity: A meaningful part of FY2025's reported 8% growth came from currency tailwinds; a stronger dollar or weaker IT budgets would slow headline growth.
3. Business Segments
IBM reports in four segments. Software is the largest and highest-margin, followed by Consulting and Infrastructure, with a small Financing arm. Figures below are full-year 2025 external segment revenue.
| Segment | % of revenue | What it is |
|---|---|---|
| Software | ~44% ($29,962m) | Hybrid Cloud (Red Hat), Automation, Data, and Transaction Processing — high-margin recurring software and the core of the AI strategy. |
| Consulting | ~31% ($21,055m) | Strategy & Technology and Intelligent Operations advisory and delivery services that help clients deploy and govern AI and hybrid cloud. |
| Infrastructure | ~23% ($15,718m) | IBM Z mainframes, distributed and hybrid infrastructure, plus support — drives hardware cycles tied to mainframe refreshes. |
| Financing | ~1% ($737m) | Client and commercial financing that supports sales of IBM's hardware, software and services. |
4. Business Model and Moat
How it makes money. IBM sells a blend of recurring software subscriptions and licences, multi-year consulting engagements, mainframe hardware and related support, and financing. The strategic centre of gravity is hybrid cloud and AI: Red Hat's OpenShift platform lets clients run workloads across on-premises and multiple public clouds, and IBM layers automation, data and watsonx AI software on top. Roughly half of revenue is now software, which carries the highest margins and the most predictable, subscription-like economics.
Where the moat comes from. IBM's durability rests on deep enterprise and government relationships, mission-critical mainframe installations with extremely high switching costs, and Red Hat's position as a neutral hybrid-cloud layer. The IBM Z mainframe remains entrenched in banking, insurance and public-sector back-ends where reliability and security are paramount, generating long, sticky hardware-plus-software cycles. A large patent portfolio and global delivery scale add further defensibility.
Why it is changing. Management has deliberately repositioned toward higher-value offerings — spinning off the managed-infrastructure business (Kyndryl) in 2021 and acquiring software assets such as HashiCorp and Confluent — to lift growth and margins. The payoff is visible in FY2025's accelerating software growth and expanding operating pre-tax margin, though consulting remains the cyclical soft spot.
5. Financial Health
IBM's revenue has grown steadily since the 2021 Kyndryl separation, with FY2025 marking a clear acceleration. All figures below are from IBM's earnings press releases and SEC filings. Revenue figures are for continuing operations.
| Fiscal Year | Revenue ($m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE, $m) |
|---|---|---|---|---|---|---|
| FY2021 | 57,350 | — | — | — | $6.55 | — |
| FY2022 | 60,530 | +5.5% | $1.95 | $9.13 | $6.59 | — |
| FY2023 | 61,860 | +2.2% | $8.15 | $9.62 | $6.63 | — |
| FY2024 | 62,753 | +1.4% | $6.42 | $10.33 | $6.67 | 49,884 |
| FY2025 | 67,535 | +7.6% | $11.14 | $11.59 | $6.71 | 54,836 |
Quarterly detail for the most recently completed fiscal year (2025), most recent quarter first, with the full-year total in bold:
| Quarter | Revenue ($m) | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| Q4 2025 | 19,686 | $4.52 | $5.86 |
| Q3 2025 | 16,330 | $2.65 | — |
| Q2 2025 | 16,977 | — | — |
| Q1 2025 | 14,541 | $1.60 | $1.12 |
| FY2025 total | 67,535 | $11.59 | $11.14 |
The balance sheet carries $66.4bn of total debt (including $12.8bn of IBM Financing debt) against $11.8bn of cash and marketable securities at the end of Q1 2026, plus a roughly $7.6bn prepaid pension asset. FY2025 operating cash flow was $13.2bn and capital expenditure just $1.6bn, reflecting an asset-light software-and-services model.
6. Valuation
Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ~$252.5bn (mid-June 2026) |
| Trailing P/E (GAAP) | ~24x (price ~$269 / FY2025 GAAP EPS $11.14) |
| P/E (forward) | ~22x (price ~$269 / Street FY2026 operating-EPS estimate ~$12.3) |
| P/S (TTM) | ~3.7x (market cap $252.5bn / FY2025 revenue $67.5bn) |
| EV/EBITDA (TTM) | ~18x (EV ~$307bn / EBITDA ~$17bn; EBITDA = FY2025 pre-tax income $10.3bn + interest ~$1.7bn + D&A $5.0bn) |
| P/FCF | ~22x (market cap $252.5bn / FCF ~$11.6bn; FCF = operating CF $13.19bn − capex $1.62bn per FY2025 cash flow statement). On IBM's own free-cash-flow definition ($14.7bn), ~17x. |
| Enterprise value | ~$307bn (market cap $252.5bn + total debt $66.4bn − cash & marketable securities $11.8bn per Q1 2026 balance sheet) |
| 52-week high | $332.46 |
| 52-week low | $212.34 |
| Short interest (% of float) | ~2.6% (latest reported, late Nov 2025) |
| Days to cover | ~2.3 |
7. Growth Drivers
The clearest driver is generative AI: IBM's AI book of business has grown past $12.5bn (inception-to-date), spanning watsonx software, SaaS contracts and consulting signings, and management cites AI as a tailwind across the portfolio. Software is the engine — Red Hat hybrid cloud grew 13% and the Data unit 19% in Q1 2026 — and the Confluent acquisition adds real-time data streaming to that stack. A second driver is the mainframe cycle: the latest IBM Z generation has produced double-digit Infrastructure growth and a 51% jump in IBM Z revenue in Q1 2026. Management has guided to more than 5% constant-currency revenue growth and roughly $1bn of year-over-year free-cash-flow growth in 2026, with productivity initiatives continuing to expand operating margins. See ChartsView's Live Charts for price action and the Economic Calendar for macro catalysts.
8. Peer Comparison
| Peer | Market cap (June 2026) | Key 2025 metric |
|---|---|---|
| Oracle (ORCL) | ~$541.6bn | Cloud-infrastructure and database leader; market cap more than double IBM's on faster cloud growth. |
| SAP (SAP) | ~$192.2bn | Enterprise-software peer migrating its base to cloud ERP; competes with IBM in enterprise automation. |
| Accenture (ACN) | ~$101.8bn | Largest pure-play IT consulting rival; direct competitor to IBM Consulting on AI and cloud transformation. |
9. Insider Activity
Recent IBM insider activity has been limited to routine equity-compensation events rather than open-market buying or selling. Chairman and CEO Arvind Krishna received scheduled restricted-stock-unit and option grants in 2026, and Senior VP & CFO James Kavanaugh disposed of shares via a gift in late 2025. There has been no material insider transaction signalling a change in conviction. The table summarises the most recent reported Form 4 activity.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| James Kavanaugh (SVP & CFO) | 05 Nov 2025 | Gift (disposal) | 6,700 | $0.00 | — | Form 4 (Code G) |
| Arvind Krishna (Chairman & CEO) | 2026 (scheduled) | RSU / option grant | — | — | — | Equity compensation |
10. Key Risks
- Consulting cyclicality (Operational). Roughly a third of revenue is advisory work exposed to enterprise discretionary budgets; consulting has been flat at constant currency and would weaken first in a downturn.
- Leverage and acquisition integration (Financial). Total debt of $66.4bn and goodwill of $74.7bn raise the stakes on integrating Confluent and prior deals; disappointing returns could pressure margins or trigger impairment.
- Competitive intensity (Operational). IBM competes against much larger hyperscalers and faster-growing software firms in cloud and AI, constraining pricing power.
- Currency and macro (Macro). A material share of reported FY2025 growth came from favourable currency; dollar strength or weaker IT spending would slow headline growth.
- Regulatory and AI-governance (Regulatory). Government-client exposure, data-privacy rules and evolving AI regulation could raise compliance costs or limit certain offerings.
11. Recent Developments
- 22 Apr 2026 — Q1 2026 results. Revenue of $15.9bn (+9%), GAAP EPS $1.28 and operating EPS $1.91; IBM reiterated guidance of more than 5% constant-currency revenue growth and about $1bn of free-cash-flow growth for 2026.
- 22 Apr 2026 — Dividend raised to $1.69. The board lifted the quarterly dividend to $1.69 per share (payable 10 June 2026), the 31st consecutive annual increase.
- 17 Mar 2026 — Confluent acquisition closed. IBM completed its ~$11bn purchase of data-streaming company Confluent at $31 per share, expanding its real-time data and AI capabilities.
- 28 Jan 2026 — Full-year 2025 results. IBM reported $67.5bn of revenue (+8%), GAAP EPS $11.14 and a generative-AI book of business above $12.5bn, capping its strongest year in some time.
12. Key Dates
- 22 Jul 2026 — expected Q2 2026 earnings release (after market close).
- 10 Jun 2026 — Q2 2026 dividend of $1.69 per share paid to holders of record as of 8 May 2026.
- Expected October 2026 — Q3 2026 earnings release.
Dates beyond the next confirmed earnings release are indicative and based on IBM's historical reporting cadence.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Explore more on ChartsView: Live Charts · Economic Calendar · Community Forum.
Loading research report…
13. Thesis Verdict
The central thesis. IBM is a hybrid-cloud and AI software-and-services company that earns most of its profit from high-margin software (Red Hat, automation, data) plus consulting, mainframes and financing. In FY2025 it grew revenue 8% to $67.5bn, posted GAAP EPS of $11.14 and operating EPS of $11.59, generated $14.7bn of free cash flow, and raised its dividend for a 31st consecutive year. Management guides to more than 5% constant-currency revenue growth in 2026, with a generative-AI book of business now above $12.5bn as the primary growth driver.
What would confirm or break it. Continued double-digit software growth, a successful Confluent integration and on-guidance Q2 2026 earnings would confirm the thesis. It would be undermined by a renewed consulting slump, weaker free cash flow, or evidence that the $66.4bn debt load and $74.7bn of goodwill are not earning their keep — the leverage/integration and competitive risks flagged in this report.
Watchpoints
- ConfirmsQ2 2026 earnings (35 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Accelerating, software-led growth:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Leverage and acquisition integration (Financial)." risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 17 Jun 2026.